MedTrace Logo

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

NCT03521180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2020-02-26

No results posted yet for this study

Summary

This is a model development, open label, no therapeutic treatment, three sequential group, short term-gluten challenge study in subjects with celiac disease. Immune responses are evaluated following gluten challenge.

Approximately fifteen subjects with celiac disease will be enrolled in up to three sequential groups (5 subjects per group).

Conditions

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • Ying Ye, PhD · Celgene

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-11
Primary Completion
2019-07-18
Completion
2019-07-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03521180 on ClinicalTrials.gov